BPSU Rare disease tea party - reports from past events

Since 2014, we've invited stakeholders from across the rare disease community to this informal networking event. Young people speak about their experiences of living with a rare disease, and patient advocates, researchers and health professionals talk about working in the field. Read on for highlights from our annual event.
Last modified
8 August 2019

2019 - focus on experience of rare disease

Thumbnail
Baroness Blackwood speaks at BPSU Rare disease tea party 2019

Baroness Blackwood, Parliamentary Under Secretary of State for Public Health and Innovation, spoke on her own experience of childhood illness to a packed audience at this year's event. She highlighted some recent achievements such as 100,000 Genomes Project and NHS Insert, a new programme that will require healthcare providers to coordinate the care of any patient with a rare disease. You can read her full speech on GOV.UK.

The incoming Deputy Chief Medical Officer for England, Prof Jenny Harries, also presented on the many challenges patients with rare disease face.

And, young people and patient advocates spoke on their experience of rare disease, including the mental and social challenges of living with these conditions, the place of rare disease within the medical education curriculum and the importance of peer support networks in creating a secure space for young people to share their experiences.

Presentations were received from Sarah Lippett, author of A Puff of Smoke, Nicola Miller from Rare Revolution Magazine and Laurence Woollard from On the Pulse amongst others.

RCPCH interns Afsan and Raheema joined, and blogged about their impressions.

2017 - focus on research

Thumbnail
Rare Disease Day 2017

Rare disease research is crucial to providing patients with the answers and solutions they need, whether it’s a treatment, cure or improved care.

Some highlights from the event:

  • We called upon researchers, universities, students, companies, policy makers and clinicians to do more research and to make them aware of the importance of research for the rare disease community.
  • We raised awareness of rare diseases through thousands of events all over the world.
  • We recognised the crucial role that patients play in research, ensuring it is better targeted to the needs of patients. Patients no longer solely reap the benefits of research; they are empowered and valued partners from the beginning to the end of the research process.

2016 - focus on patient voice

This year's event particularly recognised the crucial role that patients play in voicing their needs and in instigating change that improves their lives and the lives of their families and carers.

Thumbnail

Our slogan ‘Join us in making the voice of rare diseases heard’ appealed to a wider audience, those that are not living with or directly affected by a rare disease, to join the rare disease community in making known the impact of rare diseases. People living with a rare disease and their families are often isolated. The wider community can help to bring them out of this isolation.

The young people of Alstrom Syndrome UK, Hear my Voice Youth Forum (HMV) presented their newly designed transition resources. The resources known as T-KASH (Transition-Knowledge And Skills in Health) are aimed at young people/families and professionals. They consist of ten logos and a visual map, which can be used in any setting e.g. Hospital, GP, Health Centre to signify that adolescent health care is more than just a consultation about a medical condition/s. The message is that young people, with long term health conditions, have full and active lives. 

They also expect healthcare professionals to be able to have wider discussions about areas such as vocational choices, confidentiality or how to develop life skills. The logos draw attention to ten knowledge and skill areas that these young people say they should be competent in by the time they transfer to adult health care. Developmentally appropriate adolescent health and lifestyle competencies are what the young people want to emphasize. The logos can also be given a tactile/braille finish so that visually impaired users can read them too.

It is hoped that the resources are used to underpin transition across adolescent health.

The BPSU Rare Disease Day tea party 2016 was supported by Dirunal.

2015 - commemorating 30 years of BPSU

This was hosted in collaboration with the RCPCH Youth Advisory Panel and Rare Disease UK.

Earl Howe congratulated the BPSU on its thirtieth birthday. He highlighted the importance the government gives to delivery on the UK rare disease strategy, particularly in responding to the need for speedy diagnosis.

Presentations were given by Professor Timothy Cox of University of Cambridge and Daniel Lewi from the CATS Foundation on Tay-Sachs disease, they emphasised the importance of research and collaborative working between patients/carer, health professionals and patient organisations. Professor Timothy Barrett presented the work of the newly established NIHR Translational Research Collaboration. Dr Nick Sireau, CEO of Findacure spoke on the parent's perspective of rare disease and the importance of actively engaging with patient groups in order to develop treatments.

Thines Ganeshamoorthy from the RCPCH Youth Advisory Panel communicated his experience of living with a rare disease. Finally, Professor John Newton, the Chief Knowledge Officer from Public Health England rounded proceedings off with a presentation on the National Congenital Anomaly and Rare Disease Registration Service.

Pictures from left to right: Earl Howe; delegates networking; Dan Lewi; Prof John Newton

2014 - our first tea party

Our first event looked at the UK plan for implementing the UK strategy for rare disease.

Over 70 people attended the event including patients and carers, healthcare professionals, researchers  and policy-makers. All were united by the theme of the day 'Joining together for better care’.

This podcast was unveiled by the Youth Advisory Panel on living with a rare disease, and introduced by Earl Howe.

Presentations were received from Alastair Kent on implementing the UK strategy for rare disease; Dr Christopher Verity on undertaking rare disease research and surveillance; and Miriam Evans on patient involvement in rare disease research.